Skip to main content
Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
116.98
-2.28 (-1.91%)
At close: Apr 15, 2025, 4:00 PM
117.02
+0.04 (0.04%)
After-hours: Apr 15, 2025, 7:00 PM EDT

Biogen Revenue

In the year 2024, Biogen had annual revenue of $9.68B, down -1.62%. Biogen had revenue of $2.45B in the quarter ending December 31, 2024, with 2.87% growth.

Revenue (ttm)
$9.68B
Revenue Growth
-1.62%
P/S Ratio
1.76
Revenue / Employee
n/a
Employees
n/a
Market Cap
17.12B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20249.68B-159.70M-1.62%
Dec 31, 20239.84B-337.80M-3.32%
Dec 31, 202210.17B-808.30M-7.36%
Dec 31, 202110.98B-2.46B-18.32%
Dec 31, 202013.44B-933.30M-6.49%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck & Co. 64.17B
Pfizer 63.63B
AstraZeneca 54.07B
Novartis AG 51.72B
Sanofi 45.85B
Thermo Fisher Scientific 42.88B
Novo Nordisk 40.31B
Danaher 23.88B
Revenue Rankings

BIIB News

More News